Investigating the effect of zinc nanoparticles on the transmission of HPV infectio

Phase 3

• Conditions: Genital warts in the genitals of men.; Anogenital (venereal) warts; A63.0

• Registration Number: IRCT20190624043991N21
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 70

Inclusion Criteria

Men in the age range of 18 to 60 years who have prominent genital warts
Obtaining informed consent from patients

Exclusion Criteria

Men who have received the Gardasil vaccine according to the previous indications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The use of zinc oxide nanoparticles on HPV transmission. Timepoint: Before and 5 minutes after topical application of the ointment. Method of measurement: Molecular diagnosis laboratory (Real Time PCR ).